Report Detail
Global (United States, European Union and China) Cystic Fibrosis (CF) Therapeutics Market Research Report 2019-2025
- RnM3617530 |
- 29 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Cystic fibrosis is a genetic disease that causes continuous lung infections and breathing problem over time. It is a progressive disease. The presence of imperfect gene causes a thick, sticky buildup of mucus in the lungs, intestine liver, pancreas, and other organs. The mucus in the lungs clogs airways and traps bacteria leading to infections that causes savior lung damage, and respiratory failure. The mucus prevents in the pancreas discharge the digestive enzymes that allow the body to break down food and absorb vital nutrients. This disease is caused by mutation in gene, cystic fibrosis trans membrane conductance regulator (CFTR) is a membrane protein in vertebrates, a protein required for regulating sweat, mucus and body secretions.
In 2019, the market size of Cystic Fibrosis (CF) Therapeutics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cystic Fibrosis (CF) Therapeutics.
This report studies the global market size of Cystic Fibrosis (CF) Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cystic Fibrosis (CF) Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Vertex Pharmaceuticalsorporated
Gilead
AbbVie,
Novartis AG
F. Hoffmann-La Roche Ltd
Alaxia
Merck & Co.
AIT (Advanced Inhalation Therapies)
ALLERGAN
AstraZeneca
Teva Pharmaceutical Industries Ltd
Alcresta
Market Segment by Product Type
Pancreatic enzyme supplements
Mucolytics
Bronchodilators
CFTR modulators
Market Segment by Application
Oral drugs
Inhaled drugs
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cystic Fibrosis (CF) Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cystic Fibrosis (CF) Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cystic Fibrosis (CF) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cystic Fibrosis (CF) Therapeutics Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Pancreatic enzyme supplements
- 1.3.3 Mucolytics
- 1.3.4 Bronchodilators
- 1.3.5 CFTR modulators
- 1.4 Market Segment by Application
- 1.4.1 Global Cystic Fibrosis (CF) Therapeutics Market Share by Application (2019-2025)
- 1.4.2 Oral drugs
- 1.4.3 Inhaled drugs
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Cystic Fibrosis (CF) Therapeutics Market Size
- 2.1.1 Global Cystic Fibrosis (CF) Therapeutics Revenue 2014-2025
- 2.1.2 Global Cystic Fibrosis (CF) Therapeutics Sales 2014-2025
- 2.2 Cystic Fibrosis (CF) Therapeutics Growth Rate by Regions
- 2.2.1 Global Cystic Fibrosis (CF) Therapeutics Sales by Regions 2014-2019
- 2.2.2 Global Cystic Fibrosis (CF) Therapeutics Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Cystic Fibrosis (CF) Therapeutics Sales by Manufacturers
- 3.1.1 Cystic Fibrosis (CF) Therapeutics Sales by Manufacturers 2014-2019
- 3.1.2 Cystic Fibrosis (CF) Therapeutics Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Cystic Fibrosis (CF) Therapeutics Revenue by Manufacturers (2014-2019)
- 3.2.2 Cystic Fibrosis (CF) Therapeutics Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cystic Fibrosis (CF) Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.3 Cystic Fibrosis (CF) Therapeutics Price by Manufacturers
- 3.4 Key Manufacturers Cystic Fibrosis (CF) Therapeutics Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cystic Fibrosis (CF) Therapeutics Market
- 3.6 Key Manufacturers Cystic Fibrosis (CF) Therapeutics Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Pancreatic enzyme supplements Sales and Revenue (2014-2019)
- 4.1.2 Mucolytics Sales and Revenue (2014-2019)
- 4.1.3 Bronchodilators Sales and Revenue (2014-2019)
- 4.1.4 CFTR modulators Sales and Revenue (2014-2019)
- 4.2 Global Cystic Fibrosis (CF) Therapeutics Sales Market Share by Type
- 4.3 Global Cystic Fibrosis (CF) Therapeutics Revenue Market Share by Type
- 4.4 Cystic Fibrosis (CF) Therapeutics Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cystic Fibrosis (CF) Therapeutics Sales by Application
6 United States
- 6.1 United States Cystic Fibrosis (CF) Therapeutics Breakdown Data by Company
- 6.2 United States Cystic Fibrosis (CF) Therapeutics Breakdown Data by Type
- 6.3 United States Cystic Fibrosis (CF) Therapeutics Breakdown Data by Application
7 European Union
- 7.1 European Union Cystic Fibrosis (CF) Therapeutics Breakdown Data by Company
- 7.2 European Union Cystic Fibrosis (CF) Therapeutics Breakdown Data by Type
- 7.3 European Union Cystic Fibrosis (CF) Therapeutics Breakdown Data by Application
8 China
- 8.1 China Cystic Fibrosis (CF) Therapeutics Breakdown Data by Company
- 8.2 China Cystic Fibrosis (CF) Therapeutics Breakdown Data by Type
- 8.3 China Cystic Fibrosis (CF) Therapeutics Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Cystic Fibrosis (CF) Therapeutics Breakdown Data by Company
- 9.2 Rest of World Cystic Fibrosis (CF) Therapeutics Breakdown Data by Type
- 9.3 Rest of World Cystic Fibrosis (CF) Therapeutics Breakdown Data by Application
- 9.4 Rest of World Cystic Fibrosis (CF) Therapeutics Breakdown Data by Countries
- 9.4.1 Rest of World Cystic Fibrosis (CF) Therapeutics Sales by Countries
- 9.4.2 Rest of World Cystic Fibrosis (CF) Therapeutics Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Vertex Pharmaceuticalsorporated
- 10.1.1 Vertex Pharmaceuticalsorporated Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Cystic Fibrosis (CF) Therapeutics
- 10.1.4 Cystic Fibrosis (CF) Therapeutics Product Introduction
- 10.1.5 Vertex Pharmaceuticalsorporated Recent Development
- 10.2 Gilead
- 10.2.1 Gilead Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Cystic Fibrosis (CF) Therapeutics
- 10.2.4 Cystic Fibrosis (CF) Therapeutics Product Introduction
- 10.2.5 Gilead Recent Development
- 10.3 AbbVie,
- 10.3.1 AbbVie, Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Cystic Fibrosis (CF) Therapeutics
- 10.3.4 Cystic Fibrosis (CF) Therapeutics Product Introduction
- 10.3.5 AbbVie, Recent Development
- 10.4 Novartis AG
- 10.4.1 Novartis AG Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Cystic Fibrosis (CF) Therapeutics
- 10.4.4 Cystic Fibrosis (CF) Therapeutics Product Introduction
- 10.4.5 Novartis AG Recent Development
- 10.5 F. Hoffmann-La Roche Ltd
- 10.5.1 F. Hoffmann-La Roche Ltd Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Cystic Fibrosis (CF) Therapeutics
- 10.5.4 Cystic Fibrosis (CF) Therapeutics Product Introduction
- 10.5.5 F. Hoffmann-La Roche Ltd Recent Development
- 10.6 Alaxia
- 10.6.1 Alaxia Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Cystic Fibrosis (CF) Therapeutics
- 10.6.4 Cystic Fibrosis (CF) Therapeutics Product Introduction
- 10.6.5 Alaxia Recent Development
- 10.7 Merck & Co.
- 10.7.1 Merck & Co. Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Cystic Fibrosis (CF) Therapeutics
- 10.7.4 Cystic Fibrosis (CF) Therapeutics Product Introduction
- 10.7.5 Merck & Co. Recent Development
- 10.8 AIT (Advanced Inhalation Therapies)
- 10.8.1 AIT (Advanced Inhalation Therapies) Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Cystic Fibrosis (CF) Therapeutics
- 10.8.4 Cystic Fibrosis (CF) Therapeutics Product Introduction
- 10.8.5 AIT (Advanced Inhalation Therapies) Recent Development
- 10.9 ALLERGAN
- 10.9.1 ALLERGAN Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Cystic Fibrosis (CF) Therapeutics
- 10.9.4 Cystic Fibrosis (CF) Therapeutics Product Introduction
- 10.9.5 ALLERGAN Recent Development
- 10.10 AstraZeneca
- 10.10.1 AstraZeneca Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Cystic Fibrosis (CF) Therapeutics
- 10.10.4 Cystic Fibrosis (CF) Therapeutics Product Introduction
- 10.10.5 AstraZeneca Recent Development
- 10.11 Teva Pharmaceutical Industries Ltd
- 10.12 Alcresta
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Cystic Fibrosis (CF) Therapeutics Sales Channels
- 11.2.2 Cystic Fibrosis (CF) Therapeutics Distributors
- 11.3 Cystic Fibrosis (CF) Therapeutics Customers
12 Market Forecast
- 12.1 Global Cystic Fibrosis (CF) Therapeutics Sales and Revenue Forecast 2019-2025
- 12.2 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Type
- 12.3 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Application
- 12.4 Cystic Fibrosis (CF) Therapeutics Forecast by Regions
- 12.4.1 Global Cystic Fibrosis (CF) Therapeutics Sales Forecast by Regions 2019-2025
- 12.4.2 Global Cystic Fibrosis (CF) Therapeutics Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Cystic Fibrosis (CF) Therapeutics . Industry analysis & Market Report on Cystic Fibrosis (CF) Therapeutics is a syndicated market report, published as Global (United States, European Union and China) Cystic Fibrosis (CF) Therapeutics Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cystic Fibrosis (CF) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
